| |
(n = 2691)
|
(n = 1737)
|
|
Demographic
|
|
Age, years
|
74.70 ± 6.41
|
73.74 ± 5.17
|
|
Sex, n (%)
|
|
Male
|
1311 (48.7)
|
848 (48.8)
|
|
Female
|
1380 (51.3)
|
889 (51.2)
|
|
Ethnicity, n (%)
|
|
Non-Hispanic White
|
1675 (62.2)
|
1090 (62.8)
|
|
Non-Hispanic Black
|
453 (16.8)
|
286 (16.5)
|
|
Other Hispanic
|
75 (2.8)
|
119 (6.9)
|
|
Other races
|
488 (18.1)
|
242 (13.9)
|
|
Education, n (%)
|
|
less than high-school
|
1111 (41.3)
|
631 (36.3)
|
|
high school or above
|
1580 (58.7)
|
1106 (63.7)
|
|
Marital status, n (%)
|
|
Married
|
1477 (54.9)
|
958 (55.2)
|
|
Widowed or divorced
|
1099 (40.8)
|
694 (40.0)
|
|
Single
|
115 (4.3)
|
85 (4.9)
|
|
The income to poverty ratios, n (%)
|
|
≤1.3
|
1885 (70.0)
|
1237 (71.2)
|
|
> 1.3
|
806 (30.0)
|
500 (28.8)
|
|
Smoking, n (%)
|
|
Never
|
1312 (48.8)
|
817 (47.0)
|
|
Former
|
1152 (42.8)
|
759 (43.7)
|
|
Current
|
227 (8.4)
|
161 (9.3)
|
|
Comorbidities
|
|
Cardiovascular disease, n (%)
|
|
Absence
|
1890 (70.2)
|
1216 (70.0)
|
|
Presence
|
801 (29.8)
|
521 (30.0)
|
|
Diabetes, n (%)
|
|
Absence
|
1979 (73.5)
|
1175 (67.6)
|
|
Presence
|
712 (26.5)
|
562 (32.4)
|
|
Biomeasures
|
|
Body mass index, kg/m2, n (%)
|
|
< 25
|
735 (27.3)
|
435 (25.0)
|
|
25-30
|
1084 (40.3)
|
652 (37.5)
|
|
≥30
|
872 (32.4)
|
650 (37.4)
|
|
Systolic blood pressure, mmHg
|
148.97 ± 22.69
|
142.07 ± 21.56
|
|
Diastolic blood pressure, mmHg
|
69.90 ± 13.73
|
67.07 ± 13.34
|
|
Total cholesterol /High density lipoprotein cholesterol
|
4.07 ± 1.32
|
3.85 ± 1.32
|
|
White blood cells, 1000 cells/uL
|
7.14 ± 2.88
|
7.07 ± 2.21
|
|
Hemoglobin, g/dL
|
14.06 ± 1.45
|
13.81 ± 1.53
|
|
Platelet, 1000 cells/uL
|
251.01 ± 70.90
|
237.57 ± 69.72
|
|
Albumin, g/dL
|
41.91 ± 3.03
|
41.55 ± 3.02
|
|
Blood urea nitrogen, mg/dL
|
6.28 ± 2.84
|
6.33 ± 2.90
|
|
eGFR, mg/min/1.73 m2
|
69.94 ± 20.92
|
68.53 ± 19.52
|
|
HbA1C, %
|
5.92 ± 1.02
|
6.06 ± 0.93
|
|
Drugs
|
|
Antihypertensive drugs, n (%)
|
|
Absence
|
963 (35.8)
|
421 (24.2)
|
|
Presence
|
1728 (64.2)
|
1316 (75.8)
|
|
Hypoglycemic agents, n (%)
|
|
Absence
|
2288 (85.0)
|
1483 (85.4)
|
|
Presence
|
403 (15.0)
|
254 (14.6)
|
|
Lipid-lowering drugs, n (%)
|
|
Absence
|
1898 (70.5)
|
1016 (58.5)
|
|
Presence
|
793 (29.5)
|
721 (41.5)
|
|
Antiplatelet drugs, n (%)
|
|
Absence
|
2550 (94.8)
|
1515 (87.2)
|
|
Presence
|
141 (5.2)
|
222 (12.8)
|
|
5-year mortality, n (%)
|
|
Survival
|
2174 (80.8)
|
1440 (82.9)
|
|
Death
|
517 (19.2)
|
297 (17.1)
|
